Log In
Print
BCIQ
Print
Print this Print this
 

DMTXinvaScan

  Manage Alerts
Collapse Summary General Information
Company Oncomatrix S.L.
DescriptionImmunohistochemistry kit using a mAb developed by Oncomatrix to detect collagen type XI alpha 1 (COL11A1) gene and its encoded protein
Molecular Target
Mechanism of ActionDiagnostic; Antibody
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsDiagnose and prognose the invasiveness of tumors
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today